Minute Insight: Lumos’ Bacterial-Viral Infection Differentiation Test Flops At FDA
Lumos Diagnostics is considering an appeal of the agency’s decision to refuse market clearance for its FebriDX test.
You may also be interested in...
Reducing Antimicrobial Resistance With Rapid Tests
Widespread implementation of rapid diagnostic tests is critical for decreasing antimicrobial resistance.
Execs On The Move: New Leaders for Vyaire, Nevro, And More In May 2023
An interactive summary of recent executive-level company changes and promotions in the medical device and diagnostics sectors.
Minute Insight: Owlstone Medical’s 'Breath Biopsy' Tech Adopted By US Military
The company will create a handheld version of its FAIMS technology, to be used in rapid testing for transmissible illnesses in combat scenarios.